CADPS Antikörper (AA 1020-1100)
Kurzübersicht für CADPS Antikörper (AA 1020-1100) (ABIN6137843)
Target
Alle CADPS Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 1020-1100
-
Sequenz
- MASDMIESCV KRTRIAFEVK LQKTSRSTDF RVPQSICTMF NVMVDAKAQS TKLCSMEMGQ EHQYHSKIDE LIEETVKEMI T
-
Kreuzreaktivität
- Maus, Ratte
-
Produktmerkmale
- Polyclonal Antibodies
-
Aufreinigung
- Affinity purification
-
Immunogen
- Recombinant fusion protein containing a sequence corresponding to amino acids 1020-1100 of human CADPS (NP_899630.1).
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- WB,1:1000 - 1:2000
-
Kommentare
-
HIGH QUALITY
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- PBS with 0.02 % sodium azide,50 % glycerol, pH 7.3.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Store at -20°C. Avoid freeze / thaw cycles.
-
-
- CADPS (Ca++-Dependent Secretion Activator (CADPS))
-
Andere Bezeichnung
- CADPS
-
Hintergrund
- This gene encodes a novel neural/endocrine-specific cytosolic and peripheral membrane protein required for the Ca2+-regulated exocytosis of secretory vesicles. The protein acts at a stage in exocytosis that follows ATP-dependent priming, which involves the essential synthesis of phosphatidylinositol 4,5-bisphosphate (PtdIns(4,5)P2). Alternative splicing has been observed at this locus and three variants, encoding distinct isoforms, are described.,CADPS,CADPS1,CAPS,CAPS1,UNC-31,Signal Transduction,Neuroscience,CADPS
-
Molekulargewicht
- 50 kDa/144 kDa/148 kDa/152 kDa/153 kDa
-
Gen-ID
- 8618
-
UniProt
- Q9ULU8
-
Pathways
- Synaptic Vesicle Exocytosis
Target
-